Logotype for Mabuchi Motor Co Ltd

Mabuchi Motor (6592) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Mabuchi Motor Co Ltd

Q2 2026 earnings summary

14 Aug, 2026

Executive summary

  • Net sales for the first half of FY2026 reached ¥106.384 billion, up 12.1% year over year, driven by strong automotive and life/industrial product sales and yen depreciation.

  • Operating income rose 8.5% year over year to ¥13.147 billion, with ordinary income surging 63.3% to ¥18.891 billion, mainly due to improved foreign exchange gains.

  • Profit attributable to owners of parent grew 41.9% year over year to ¥12.693 billion.

  • Major acquisitions included Nippon Pulse Motor Co., Ltd. and MASDAC Co., Ltd., expanding the group’s reach in motion control and food machinery sectors.

  • Life and industrial product sales increased due to M&A consolidation and currency trends, despite selective order taking and inventory adjustments in some segments.

Financial highlights

  • Gross profit for the first half was ¥32.528 billion (30.6% margin), up 14.7% year over year.

  • Comprehensive income reached ¥24.953 billion, a significant turnaround from a loss of ¥6.557 billion in the prior year.

  • SG&A expenses increased 19.3% year over year, reflecting investments to support growth.

  • Effective tax rate increased by 7.2 percentage points year over year to 32.3%.

  • Interim dividend set at ¥35 per share, with a record-high full-year dividend forecast of ¥70 per share.

Outlook and guidance

  • Full-year FY2026 net sales forecast is ¥225.0 billion, up 12.3% year over year.

  • Operating income for the full year is projected at ¥26.5 billion, up 4.1% year over year; ordinary income at ¥31.3 billion (down 10.8%), and profit attributable to owners of parent at ¥22.2 billion (down 15.5%).

  • Outlook reflects expected cost pressures from M&A, R&D, and infrastructure investments, offset by improved pricing and product mix.

  • Automotive product sales are expected to grow despite a slight decline in global automobile production, aided by yen depreciation.

  • Life and industrial product sales are forecast to remain steady, with stable demand in health and medical applications.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more